Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Yu%2C+Zhuang%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
/vufind/Search/Results?lookfor=%22Yu%2C+Zhuang%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
Search /vufind/Search2/Results?lookfor=%22Yu%2C+Zhuang%22&type=Person&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
PubPharm (13)
1
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
enthalten in:
Cancer communications (London, England)
| 2024
von
Zheng, J.
|
Wang, T.
|
Yang, Y.
| +41
Wird geladen...
2
Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
enthalten in:
Journal for immunotherapy of cancer
| 2023
von
Zhong, H.
|
Zhang, X.
|
Tian, P.
| +13
Wird geladen...
3
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer : a Phase I/II Trial
enthalten in:
Signal transduction and targeted therapy
| 2023
von
Lu, S.
|
Pan, H.
|
Wu, L.
| +31
Wird geladen...
4
Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy : A Phase 2, Multicenter, Single-Arm, Open-Label Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Lu, S.
|
Zhang, Y.
|
Zhang, G.
| +52
Wird geladen...
5
AENEAS : A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Lu, S.
|
Dong, X.
|
Jian, H.
| +56
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3103-3105. - PMID 35679530
Wird geladen...
6
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC : Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Lu, S.
|
Wang, Q.
|
Zhang, G.
| +39
CommentIn: Nat Rev Clin Oncol. 2022 Jan;19(1):6. - PMID 34845385
Wird geladen...
7
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Yang, Y.
|
Huang, J.
|
Wang, T.
| +41
Wird geladen...
8
Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non-small cell lung cancer with sensitive EGFR mutations
enthalten in:
Clinical and translational science
| 2021
von
Zhang, Y.
|
Wang, J.
|
Yu, Z.
| +3
Wird geladen...
9
Subgroup analysis by prior anti-VEGF or anti-EGFR target therapy in FRESCO, a randomized, double-blind, Phase III trial
enthalten in:
Future oncology (London, England)
| 2021
von
Xu, R.
|
Qin, S.
|
Guo, W.
| +31
Wird geladen...
10
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer : a multicentre, phase 2 trial
enthalten in:
The Lancet. Respiratory medicine
| 2020
von
Yang, Y.
|
Zhou, J.
|
Zhou, J.
| +37
CommentIn: Lancet Respir Med. 2020 Jan;8(1):5-7. - PMID 31628086
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: EC 2.7.10.1
Medienart
13
Aufsätze
13
E-Artikel
13
E-Ressourcen
Zeitschriftentitel
3
Journal of thoracic oncology : official publica...
1
Cancer communications (London, England)
1
Clinical and translational science
1
Future oncology (London, England)
1
Journal for immunotherapy of cancer
1
Journal of clinical oncology : official journal...
1
Lung cancer (Amsterdam, Netherlands)
1
Molecular diversity
1
Oncology reports
1
Signal transduction and targeted therapy
1
The Lancet. Respiratory medicine
Alle anzeigen ...
weniger ...
Thema
EC 2.7.10.1
13
Journal Article
8
ErbB Receptors
8
Protein Kinase Inhibitors
8
Research Support, Non-U.S. Gov't
7
EGFR protein, human
6
Clinical Trial, Phase II
6
Multicenter Study
3
Acrylamides
3
Anaplastic Lymphoma Kinase
3
Piperazines
3
Pyridazines
3
Pyrimidines
3
Quinazolines
3
SMA5ZS5B22
3
ensartinib
2
04Q9AIZ7NO
2
53AH36668S
2
Aniline Compounds
2
Circulating Tumor DNA
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
13
Englisch
Haven't found what you're looking for?
Wird geladen...